Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.

MLA

Ebrahimi, Fahim, et al. “Familial Coaggregation of MASLD with Hepatocellular Carcinoma and Adverse Liver Outcomes: Nationwide Multigenerational Cohort Study.” Journal of Hepatology, vol. 79, no. 6, Dec. 2023, pp. 1374–84. EBSCOhost, https://doi.org/10.1016/j.jhep.2023.08.018.

APA

Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023). Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study. Journal of Hepatology, 79(6), 1374–1384. https://doi.org/10.1016/j.jhep.2023.08.018

Chicago

Ebrahimi, Fahim, Hannes Hagström, Jiangwei Sun, David Bergman, Ying Shang, Wen Yang, Bjorn Roelstraete, and Jonas F. Ludvigsson. 2023. “Familial Coaggregation of MASLD with Hepatocellular Carcinoma and Adverse Liver Outcomes: Nationwide Multigenerational Cohort Study.” Journal of Hepatology 79 (6): 1374–84. doi:10.1016/j.jhep.2023.08.018.